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Dysfunction
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50 years old female patient with a medical history of hypertension presented to the clinic
with chest pain, palpitations, and dyspnea on exertion of 2 years duration. Extensive
workup in search of the culprit etiology of her chest pain revealed a challenging
combination of an anomalous left anterior descending artery withmyocardial bridging and
endothelial dysfunction. She was treated medically with long acting nitrates, L-arginine
and calcium channel blockers, and remains asymptomatic after 12 months of follow up.
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INTRODUCTION
Ectopic origin of coronary artery (EOCA), vasospasm secondary to endothelial dysfunction (ED)
and myocardial bridging (MB) can all cause angina. Congenital anomalies of coronary arteries are
common in hearts with other cardiovascular malformations, such as transposition, tetralogy, or
truncus arteriosus (1). They also exist in isolation in 0.5–2.2% of the population and have been
implicated as a cause of sudden death especially in young athletes (1–4). Myocardial bridging,
on the other hand, is more prevalent as it is noted in 40–80% on autopsy with functional MB
being prevalent in up to 16% by angiography (5). It is also common to have ED within the MB
leading to myocardial ischemia (5, 6). We herein report the case of a 50 years old female patient
presenting with chest pain and dyspnea and found to have an unusual challenging combination of
anomalous left anterior descending artery (LAD) arising from the right coronary artery (RCA) with
MB and ED.
CASE REPORT
A 50 years old obese (BMI 32) female with a medical history significant for treated hypertension
presented to the clinic with chest pain, palpitations, dyspnea on exertion and decreased functional
capacity of 2 years duration. Patient reports that she has always been physically active. She denies
tobacco use and any family history of sudden cardiac death.
On presentation, patient was alert, oriented and in no acute distress. She had a resting heart rate
of 52 beats per minute and a blood pressure of 120/68mmHg. On cardiac examination, her rate and
rhythm were regular without audible murmurs, rubs or gallops, and no jugular venous distention.
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Lungs were clear to auscultation, and respirations were
non-labored. The remainder of the physical examination
was unremarkable.
FIGURE 1 | Coronary computed tomography angiogram (CTA) with 3D reconstruction. (A) Yellow circle denotes LAD anomalously arising from proximal RCA without
a slit like orifice and coursing between aortic root and RVOT. (B) Yellow line denotes LAD with an intra-myocardial segment. (C) Yellow circle denotes LAD with an
intra-myocardial segment in cross section. (D,E) RCA coursing into left atrioventricular groove to supply circumflex artery. (F) LAD arising anomalously from
proximal RCA.
FIGURE 2 | Coronary Angiogram. (A) RCA providing blood flow to the circumflex and obtuse marginal arteries. (B) Yellow circle denotes LAD arising anomalously
from proximal RCA. (C,D) Yellow line denotes LAD myocardial bridge with spontaneous vasospasm and vasospasm of distal RCA. (E,F) Improvement of
intramyocardial LAD segment and distal RCA calibers after intracoronary nitroglycerine.
On first visit to the clinic, electrocardiogram (ECG) showed
sinus bradycardia with a heart rate of 47 beats per minute;
transthoracic echocardiogram demonstrated an ejection fraction
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(EF) of 48% consistent with mildly diminished left ventricular
systolic function without definitive regional wall abnormality.
Laboratory workup was normal.
She then had a treadmill stress echocardiogram in 1 week
which was negative for ischemia and showed a resting EF of
45%, an EF of 55% at peak exercise and global hypokinesis at
both rest and stress. Because of her anginal chest pain and left
ventricular systolic dysfunction, coronary computed tomography
angiogram (CTA) was performed and the patient was started
on angiotensin converting enzyme inhibitor; beta blockers were
withheld because of her bradycardia.
Coronary CTA demonstrated a very large dominant RCA
coursing distally into the left atrioventricular (AV) groove to
supply the circumflex (Cx) artery (Figures 1D,E); LAD arising
anomalously from proximal RCA without a slit like orifice
(Figures 1A,F) and coursing between the aortic root and right
ventricular (RV) outflow tract (Figure 1A); LAD with an intra-
myocardial segment (Figures 1B,C). Coronary CTA showed no
coronary calcification or stenosis.
She was started on non-dihydropyridine calcium channel
blockers (CCB); however, her symptoms persisted on 1 month
follow up and therefore a coronary angiogram was performed to
assess extent of LADMB and possible presence of vasospasm/ED
in preparation for potential surgery to treat anomalous LAD.
Coronary angiogram showed a superdominant RCA providing
blood flow to the Cx and obtuse marginal arteries (Figure 2A);
LAD arising from proximal RCA (Figure 2B) with a long bridged
segment (intramyocardial course) with spontaneous vasospasm,
along with vasospasm of distal RCA segments (Figures 2C,D).
With intracoronary nitroglycerine, the intramyocardial LAD
segment and distal RCA vessel calibers improved (Figures 2E,F),
consistent with diagnosis of vasospasm secondary to ED.
Given her anomalous left coronary artery and the extent of
LADMB, cardiac surgery were consulted and the decision was to
treat medically with long acting nitrates, L arginine and a higher
dose of CCB. That decision was based on the fact that her LAD
was relatively a small artery with very long segment ofMB that we
did not believe would be amenable for surgery. Patient was also
instructed to avoid smoking and vigorous exercise. On follow-
up at 1 and 12 months, patient has been overall well-managed
with medical therapy, remains asymptomatic and tolerating her
medications well.
Table 1 summarizes the timeline of events.
DISCUSSION
Anomalous LAD arising from RCA and having an intra-arterial
course has been associated with sudden death and often requires
surgical intervention (7). This case illustrates that although CT
coronary angiography can delineate the current anatomy very
well in patients with ectopic coronary artery origin, at times as
illustrated in this case, coronary angiography provides an added
value to the evaluation especially in presence of MB. We usually
do vasoreactivity testing using acetylcholine to evaluate for
epicardial and microvascular dysfunction; however, in our case
given the amount of spontaneous vasospasm within the bridge,
TABLE 1 | Timeline of events.
At presentation • Chest pain, palpitations, dyspnea on exertion and
decreased functional capacity of 2 years duration
• ECG showing sinus bradycardia
• TTE demonstrating an ejection fraction of 48% with
borderline to mildly diminished left ventricular function
• Normal laboratory workup
1 week after
presentation
• Treadmill stress echocardiogram negative for
ischemia and showing a resting EF of 45%, an EF of
55% at peak exercise and global hypokinesis at both
rest and stress
• Started on angiotensin converting enzyme inhibitor
3 weeks after
presentation
• Coronary CTA showing:
◦ Very large RCA coursing distally into the left AV
groove to supply the circumflex
◦ LAD arising anomalously from proximal RCA
without a slit like orifice
◦ LAD intra-arterial between aortic root and RVOT
◦ LAD with an intra-myocardial segment
◦ No coronary calcification or stenosis
• Started on CCB
2 months after
presentation
• Persistent symptoms despite being on CCB
• Coronary angiogram showing:
◦ Superdominant RCA providing blood flow to the
circumflex and obtuse marginal arteries
◦ LAD arising from proximal RCA has a long bridged
segment with vasospasm, along with spasm of
distal RCA segments
◦ Intracoronary nitroglycerin increased
intramyocardial vessel and distal RCA caliber
suggesting vasospasm/ED
• Started on long acting nitrates, L-arginine, and
higher dose of CCB
3 months and 1 year
after presentation
• Asymptomatic
ECG, electrocardiogram; TTE, transthoracic echocardiogram; EF, ejection fraction; CTA,
computed tomography angiogram; RCA, right coronary artery; AV, atrioventricular; LAD,
left anterior descending; RVOT, right ventricular outflow tract; CCB, calcium channel
blocker; ED, endothelial dysfunction.
and the associated high prevalence of endothelial dysfunction
with MB, we didn’t pursue a vasoreactivity test as we felt it
would be unsafe to further induce vasospasm. In addition, this
case demonstrates the clinically challenging association of EOCA
with MB and ED in a symptomatic patient with angina who
improved with medical therapy rather than surgical intervention.
ED and/or vasospasm can occur withinMB and can be associated
with EOCA. They can be successfully treated with nitrates, L-
arginine (8) and CCB.
CONCLUSION
Symptomatic patients with EOCA should routinely be considered
for invasive assessment of coronary vasoreactivity to identify
culprit etiology before considering any surgical intervention. ED
and/or vasospasm within MB could be associated with EOCA
and be treated medically. First line therapies for ED are nitrates,
L-arginine and CCB, while first line therapies for symptomatic
MB are CCB and BB.
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